Stock NRXS NEURAXIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News NeurAxis, Inc.

Equities

NRXS

US64134X2018

Market Closed - Nyse
Other stock markets
 21:10:00 18/06/2024 BST 		5-day change 1st Jan Change
2.8 USD +0.36% Intraday chart for NeurAxis, Inc. -6.04% +4.87%
06-07 NeurAxis Submits Application to FDA to Expand IB-Stim Label MT
05-22 Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635 MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NeurAxis Submits Application to FDA to Expand IB-Stim Label
MT
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure
GL
Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635
MT
NeurAxis Reports First Quarter 2024 Financial Results
GL
Neuraxis, Inc. Provides Earnings Guidance for Late 2024 and 2025
CI
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
GL
NeurAxis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
GL
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
AQ
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024
GL
NeurAxis Announces New Medical Policy Coverage in North Dakota
GL
NeurAxis, Inc. Terminates Dan Clarence as Chief Operating Officer
CI
NeurAxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
GL
NeurAxis, Inc. Provides Revenue Guidance in Late 2024 and into 2025
CI
NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024
GL
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
GL
NeurAxis, Inc. Announces IB-Stim Results from A Large, Pediatric, Multi-Center Registry
CI
NeurAxis Announces Highmark BCBS Policy Coverage
GL
Neuraxis, Inc. Appoints Kristin Ferge to the Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NRXS Stock
  4. News NeurAxis, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW